# Sprint 178 — Milestone 30 Closeout and M31 Handoff

## Status

**Documentation implementation complete; Founder review and manual merge pending.**

## Objective

Formally close Milestone 30 after successful Founder Standard/Demo acceptance,
record the final portfolio-review product outcome and remaining boundaries, and
hand the repository to Milestone 31 architecture planning.

This sprint is CTO-owned and documentation-only.

## Starting Point

Sprint 178 starts from merged `main` SHA:

```text
ca1025bf98f78147c3cf86a140e1a08e983f73db
```

Before the sprint:

- PR #352 was merged;
- Issue #351 was closed as completed;
- Sprints 169–177 were merged;
- migration head was `0006_portfolio_reviews`;
- no open Issue or PR existed; and
- M30 remained In Progress only because the formal closeout had not merged.

## Evidence Reviewed

The closeout reviewed:

- M30 architecture and milestone planning;
- merged S169–S177 Issue and PR records;
- source, scenario, analysis, artifact, persistence, API, Web, Demo, and runtime
  packaging documentation;
- green deterministic repository checks from the implementation PRs;
- the S177 migration-resource incident and recovery design; and
- the Founder's completed local acceptance report.

Founder acceptance confirmed:

```text
preserved Standard 0005 -> 0006 upgrade
Standard read-only verification and MVP smoke
Demo Workspace dataset/descriptor v2
exact review create prefill and replay
explicit decision persistence across Demo restart
return-to-Standard storage isolation
English and Simplified Chinese browser acceptance
```

## Closeout Decision

After this PR merges:

```text
Milestones 1–30 — Complete
Sprints 169–178 — Complete
M31 — Next / architecture planning
M32–M36 — Approved planned sequence
migration head — 0006_portfolio_reviews
```

M30 is closed because every approved exit criterion is implemented, verified,
and accepted without adding M31–M36 behavior prematurely.

## Documentation Changes

This sprint adds:

```text
docs/closeouts/milestone-030-portfolio-level-decision-review-foundation-closeout.md
docs/sprints/sprint-178-milestone-030-closeout-and-m31-handoff.md
```

It updates the canonical milestone, architecture, project context, README, and
roadmap records so they agree on M30 completion and the M31 handoff.

## M31 Handoff

The next milestone is:

```text
M31 — Stateful Paper Account and Ledger Foundation
```

M31 must establish account and ledger truth independently from M30 review
evidence. An approved M30 review may be referenced, but it cannot create, fund,
or mutate an account and is not a cash, position, order, fill, fee, or ledger
record.

The next action after merge is an M31 architecture-and-planning Issue. Direct M31
implementation is not authorized by this closeout.

## Preserved Boundaries

Sprint 178 changes no:

- runtime Python or TypeScript;
- tests;
- dependencies or lockfiles;
- OpenAPI or generated contracts;
- migrations or database schema;
- Docker or Compose configuration;
- portfolio-review calculations or behavior;
- Standard/Demo storage or data;
- Paper Job or lifecycle behavior;
- account, market, order, execution, worker, broker, QMT, MiniQMT, private-edge,
  live, or real-money capability; or
- proxy configuration.

## Verification

The authoritative repository verification is:

```text
uv run python scripts/check.py
```

The CTO connector environment does not provide a runnable checkout, so Sprint
178 relies on the pull-request CI quality gate. No Docker, migration, browser,
backup, reset, or other runtime operation is required for this documentation-only
closeout. Founder runtime acceptance was completed before Sprint 178 and is
recorded as reviewed evidence, not rerun by the CTO.

## Pull Request Contract

Branch:

```text
cto/sprint-178-m30-closeout-m31-handoff
```

Title:

```text
Sprint 178 — Milestone 30 Closeout and M31 Handoff
```

The PR must:

- begin with `Closes #353`;
- be Ready for review;
- state documentation-only scope and no runtime/schema change;
- retain Founder manual merge authority; and
- remain unmerged until Founder review.